ReviewBMC nephrology2025
Emerging roles of non-coding RNAs in idiopathic nephrotic syndrome: a narrative review.
Review in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nephrotic syndrome (NS) is a clinical situation characterized by excessive proteinuria (greater than 3-3.5 g/24 hour or spot urine protein:creatinine ratio of > 300-350 mg/mmol), hypoalbuminemia, edema, and always along with hyperlipidemia. Currently, only a minority of nephrotic syndrome cases have been identified as having genetic associations, while the pathogenic mechanisms responsible for the condition remain largely elusive in the majority of patients. Renal biopsy is generally essential for the definitive and differential diagnosis. Recently, non-coding RNAs (ncRNAs), especially microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), were demonstrated to be involved in the pathogenesis and development of idiopathic nephrotic syndrome (INS). In this review, we discussed and summarized the biological properties and multiple functions of ncRNAs in the progression of INS, and also offer a glimpse into their potential as specific diagnostic tools and therapeutic options for INS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.